
All posts by Abdullah Zafar

Team Al Jalila – Running for a Reason at the 2019 Standard Chartered Dubai Marathon

HH Sheikh Ahmed Bin Saeed
Al Maktoum

Khalaf Ahmad Al Habtoor

Harmony, at the Heart of the Nation
December 2018
This 47th National Day once again brought with it a wonderful celebration of unity and harmony that makes all of us feel a part of this great country. By marking UAE National Day, we also honour the legacy of His Highness Sheikh Zayed bin Sultan Al Nahyan, Father of the Nation and the first President of the United Arab Emirates and reflect on the values that continue to guide us: wisdom, respect, sustainability and human development. As a special tribute to Sheikh Zayed, one of the world’s greatest philanthropists, we launched Zayed – 100 Years of Inspiration, a book to bring to life.

Saffron key in cancer treatment
According to the World Health Organization cancer is the second leading cause of death globally and researches around the world continue to search for a cure. Al Jalila Foundation research grant recipient, Professor Amr Amin from United Arab Emirates University, has been conducting a study since 2011 and found saffron to have anti-liver cancer properties working both to stop cell division and promote cell death. The study was first published in the Hepatology Journal. A multifaceted disease like cancer should be approached with therapies that target multiple biochemical and physiological pathways. Saffron has been used in folk medicine for centuries. Anticarcinogenic activity of saffron was reported at the beginning of 1990 and research on this subject has increasingly continued during the past decade.
Introduction of a natural compound-based active ingredient to the cancer therapeutics would be an advancement in relation to the serious issues of drug resistance, relapse, and effective dose, etc. Given the current limited treatment options for liver cancer, introducing safranal as a novel therapeutic drug against liver cancer is needed. With the same objective, Professor Amin’s study is assessing the anti-tumor properties of safranal with and without sorafenib in Hepatocellular carcinoma (HCC) cells and investigating the transcriptional and translational effects of safranal on angiogenesis of HCC cells.
Professor Amr’s study advocates that the active components of natural products can be curative and protective in a sense of evoking less side effects; thereby enhancing the efficiency of isolated or synthesized chemical compounds with the ultimate possibility to inhibit or even reverse tumor development.
National Charity School Dubai Empowering Children of Determination
Khalid’s Story of Hope
Farah, Spreading Joy to Sick Children
